EGETIS THERAPEUTICS AB

Transcripts Egetis Therapeutics AB

Equities

EGTX

SE0003815604

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 28/06/2024 BST			5-day change	1st Jan Change
4.67 ^SEK	-6.32%		-25.52%	-16.31%

06-20	Transcript : Egetis Therapeutics AB - Special Call
06-19	Egetis Therapeutics AB Announces Topline Results of the Phase 2 Triac Trial II with Emcitate for MCT8 Deficiency	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Egetis Therapeutics AB - Special Call	06-20
Transcript : Egetis Therapeutics AB - Analyst/Investor Day	12-19
Transcript : Egetis Therapeutics AB - Special Call	29/06/23
Transcript : Egetis Therapeutics AB - Analyst/Investor Day	13/10/22
Transcript : PledPharma AB, Rare Thyroid Therapeutics International AB - M&A Call	05/10/20
Transcript : PledPharma AB - Special Call	06/04/20
Transcript : PledPharma AB - Special Call	02/03/20
Transcript : PledPharma AB - Special Call	23/01/20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer